Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000169

Chairperson & CEO sold 9,500 shares at an average $560.07 ($5,320,681)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

15 lines
Date Transaction Shares Price Value Owned after D/I
2026-10-21 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $117.76 $1,118,720 333,943 I
2026-10-21 Sale : show line 2 in the form 10b5-1 −46 $552.52 $25,416 333,897 I
2026-10-21 Sale : show line 3 in the form 10b5-1 −194 $553.78 $107,434 333,703 I
2026-10-21 Sale : show line 4 in the form 10b5-1 −550 $555.19 $305,357 333,153 I
2026-10-21 Sale : show line 5 in the form 10b5-1 −567 $556.41 $315,486 332,586 I
2026-10-21 Sale : show line 6 in the form 10b5-1 −1,702 $557.25 $948,432 330,884 I
2026-10-21 Sale : show line 7 in the form 10b5-1 −1,137 $558.32 $634,808 329,747 I
2026-10-21 Sale : show line 8 in the form 10b5-1 −743 $559.25 $415,521 329,004 I
Open-market sales · 9,500 sh · avg $560.07 · $5,320,681

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-10-21 Exercise or conversion : show line 16 in the form 10b5-1 Stock Option −9,500 185,910 I
Loading xslF345X06/primarydocument.xml…